jueves, 25 de julio de 2019

STAT Plus: Patients, backed by ‘dark money’ group, get ready to debate Duchenne drug prices. It will not be boring By KATE SHERIDAN

Daily Recap

STAT Plus: Patients, backed by ‘dark money’ group, get ready to debate Duchenne drug prices. It will not be boring

By KATE SHERIDAN

CRAIG F. WALKER/THE BOSTON GLOBE
Meetings of the Institute for Clinical and Economic Review don’t usually get one’s heart pumping. A Duchenne meeting may prove the exception to the rule.

No hay comentarios: